Press Releases & Presentations

 
(Swipe to view full table)
  Date Title and Summary View

Dec 12, 2012

Accelerate Diagnostics goes to NASDAQ
DENVER, Dec. 12, 2012 /PRNewswire/ -- Accelr8 Technology Corporation (NYSE MKT: AXK) announced today that its common stock has been approved by The NASDAQ Stock Market, LLC for listing on the NASDAQ Capital Market. The Company expects to commence trading on NASDAQ under the ticker symbol "AXDX" on Wednesday, December 26, 2012. Until such date, th...Read more

Jun 27, 2012

Accelr8 Announces New Management
Denver, Co., June 26, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) today announced the appointment of Lawrence Mehren as President and Chief Executive Officer and a member of the Board of Directors. Most recently, Mr. Mehren was Head of Global Business of Ventana Medical Systems and Roche Tissue Diagnostics, managing its four busi...Read more

Jun 26, 2012

Accelr8 Closes on Investment
Denver, Co., June 26, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) announced today that it has received shareholder approval, met all closing conditions, and has consummated a transaction that will result in an investment of up to $35 million in Accelr8's common stock. The purpose is to complete the product development and market ...Read more

Jun 22, 2012

Accelr8 Presents Two Studies at ASM 2012 and Receives Acceptance to Present a New Blood Study
Denver, Co., June 22, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) announced results of two studies that it presented at the 112th annual General Meeting of the American Society for Microbiology (www.asm.org). The first study used the company's BACcel™ rapid automated diagnostic system with positive blood cultures to detect a...Read more

May 15, 2012

Accelr8 and Denver Health Notified by Department of Defense for Rapid Diagnostics Award
DENVER, Colo., May 15, 2012 – Accelr8 Technology Corporation (NYSE MKT: AXK) and Denver Health received notice that the Defense Medical Research and Development Program (DMRDP) recommended $2 million funding of a proposed 35-month project submitted jointly by Denver Health and Accelr8. The DMRDP solicited proposals to "advance state-of-the...Read more

Apr 23, 2012

Accelr8 Attracts Up To $35 Million Private Equity Investment
DENVER, Colo., April 23, 2012 – Accelr8 Technology Corporation (Amex: AXK) announced today that an investment group formed by Jack Schuler, John Patience, and Larry Mehren will invest a total of up to $35 million in Accelr8's common stock. The purpose is to complete the product development and market introduction of Accelr8's BACcel™ ...Read more

Nov 22, 2011

Accelr8 Announces Development Expansion for Blood-Based Diagnostic Tests
DENVER, Colo., November 22, 2011 – Accelr8 Technology Corporation (NYSE Amex: AXK) announced that it successfully completed two technical feasibility studies for test methods that expand its BACcel™ rapid diagnostic test library and automation capabilities. The first is a same-day multi-pathogen, multiple drug resistance diagnostic pa...Read more

Oct 13, 2011

Accelr8 Announces Interim Plan and Advanced Studies
DENVER, Colo., October 13, 2011 – Accelr8 Technology Corporation (NYSE Amex: AXK) announced that upon reaching the end of its technology evaluation agreement with Novartis (Sep 30, 2011), discussion has now shifted to searching within Novartis for funding vehicles. This transition follows Novartis business analyses and successful Proof of ...Read more

Sep 22, 2011

Accelr8 Announces Renewal and Expansion of SCHOTT Microarray License, and Notice of Allowance for New Patent
DENVER, Colo., September 22, 2011 – Accelr8 Technology Corporation (NYSE Amex: AXK) announced that Accelr8 and SCHOTT Technical Glass Solutions, GmbH (Jena, Germany) have renewed Accelr8's license to SCHOTT for Nexterion┬« microarraying slides using OptiChem┬« biocoatings. In addition to renewing the existing non-exclusive license, Accelr8 a...Read more

Sep 19, 2011

Accelr8 Announces Results in Award-Winning Presentation for Rapid Diagnostics with ICU Specimens
CHIGACO, Ill., September 19, 2011 – Accelr8 Technology Corporation (NYSE Amex: AXK) announced results presented at the 51st ICAAC held in Chicago on September 17. As previously announced in July, the presenters received an award for an "outstanding presentation of an abstract accepted by ICAAC." The presentation title is "Same-Shift ID Dir...Read more
FirstPrevious
1
...
4
5
6
7
Next Last

= add release to Briefcase
NASDAQ: AXDX
$ 22.05
-0.35
(1.56%)
12:15 PM ET on Sep 26, 2017
Day High: 22.65
Day Low:  22.00
Volume:    64,114
Delayed ~20 min., by eSignal.

Want to receive investor-related news and updates?

Join our mailing list

Other updates